MedTrace Logo

Study for Novel Coronavirus Pneumonia (NCP)

NCT04283396 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-03-17

No results posted yet for this study

Summary

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Conditions

  • Novel Coronavirus Pneumonia

Interventions

COMBINATION_PRODUCT

systemic treatment

Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2020-05-30
Completion
2020-07-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04283396 on ClinicalTrials.gov